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The Domino Effects of Synbiotic: 
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Flávia Pelá
Abstract
Around of 60,000 tons per year of antibiotics are consumed to produce our food 
through subtherapeutic dosage usage which aim is improve healthy and perfor-
mance of animal in intensive system production. If the use of antibiotics allowed 
greater access to food, on the other hand, it allowed a selective pressure of anti-
microbial resistant strains, the superbugs. Considered a worldwide public health 
problem, this ultimately led to the prohibition of antibiotics as growth enhancers 
in animal production and the synbiotic, prebiotic and probiotic, is claimed to be 
effective alternative to withdraw of antibiotics in poultry farm. Hence, in this 
chapter, an antimicrobial resistance, animal health regulatory affairs and synbiotic 
influences will be summarized. The results of scientific assays and field trials from 
our synbiotics commercial formulations will be described to concerning the effect 
of zootechnical performance and sanitary control in the poultry production.
Keywords: synbiotics additive, antimicrobial resistance, poultry production,  
quality food, human health
1. Introduction
The human health is intrinsically associated from health and nutrition to animal 
and plants. This direct proportionality stems from the fact of that animals and 
plant, as food, can be by a direct source of contamination by pathogens, is been a 
common strain or an antimicrobial resistance strain [1].
The constant growth of human population rise the food demand which imply in 
a better intensive animal productivity. The intensive system has several challenges 
to produce eggs, meat, milk, fish and others, with high productivity, low costs and 
a quality and safety standard conditions. One of the most practices to improve 
the animal production is a use of subtherapeutic dosages of antibiotics for animal 
growth performance and sanitary control [1].
However, since 1970, the international agencies like as World Health 
Organization (WHO), Food and Agriculture Organization of the United Nations 
(FAO), U.S. Food and Drug Administration (FDA), World Organization for Animal 
Health (OIE) are doing severe appointments through by global public campaign for 
limit and/or ban the use of antibiotics as feed additive, because, this subtherapeutic 
practical for growth performance is one of the causes that triggers antimicrobial 
resistance from the selective pressure carried out by antibiotics [2–4].
Antimicrobial resistance, nowadays, is one of public health problem in the 
world. Each year it causes the death of more than 700,000 people worldwide, which 
the most common serotypes of infections are being Salmonella ssp., followed by 
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Escherichia coli and Staphylococcus aureus. Spending on patient care is high, reaching 
costs of around $29,000 per patient in the United States.
Efforts to substitute the antibiotics are occurring and the synbiotics additive 
has been one of potential alternative feed additives for the banned antibiotic-based 
stimulators [2–4].
Synbiotic is described by “a mixture comprising live microorganisms and 
substrate(s) selectively utilized by host microorganisms that confers a health 
benefit on the host” [5]. Refers to nutritional supplements combining prebiotic and 
probiotic in complementary or synergism form which will beneficially affect the 
host by improving the implantation of live microbial dietary supplements in gastro-
intestinal (TGI) tract by selectively stimulating the growth and/or by activating the 
metabolism of one on limited number of health promoting bacteria [6, 7].
The mechanisms of synbiotic influence the host is the prebiotic stimulates 
growth of probiotic bacteria or the prebiotic and probiotic act independently 
in the GIT tract, both stimulating the intestinal microbiota. Non-digestible ele-
ments (prebiotics) are fermented in the GIT, while beneficial live microorganisms 
(probiotics) colonize it [5].
In this chapter, an antimicrobial resistance, animal health regulatory affairs and 
synbiotic influences will be summarized. The results of scientific assays and field 
trials from our synbiotics commercial formulations will be described to concern-
ing the effect of zootechnical performance and sanitary control in the poultry 
production.
2. The domino effect
2.1 Antibiotic resistance
Antibiotics are in fact one of the best drugs developed. Initially applied for the 
treatment of infections, these drugs revolutionized modern medicine and changed 
the therapeutic paradigms [8]. Discovered in 1928 by Alexandre Fleming with 
penicillin, successive antimicrobials were developed and applied in the period 
between 1930 and 1960, the golden age [9–11]. However, concurrently with the 
findings, resistance to antibiotics has been identified, with the marked increase in 
patients relapsing to the infection of common bacterial pathogens. The truth is that 
every molecule used in the treatment of bacteria, fungi, parasites, viruses and, still, 
chronic diseases, by biochemical and physiological mechanisms favor the potential 
development of tolerance or resistance to the compound since the first use [10, 11]. 
This resistance associated with factors such as: overpopulation, improved global 
migration, indiscriminate use of antibiotics, as well as, the incorrect use neglect-
ing the prescribed treatment, the intensification of animal production and the 
underdosing used as a zootechnical additive, selective pressure and basic sanitation 
precarious conditions have accentuated antibiotic resistance by living beings, mak-
ing it one of the most important threats to public health in the 21st century, accord-
ing to the WHO [2, 8, 12].
Results of genomic studies indicate the existence of more than 20,000 potential 
resistance genes (r genes) with about 400 different types [10], which mutation, 
horizontal gene transfer, conjugation and transduction are key hypothesis of the 
selective pressure that contributes to the distribution and co-selection of resistance 
and virulence genes. The impact of this selective pressure is reflected in the mecha-
nisms of action of pathogenic strains that, in general, can modify the target site of 
antibiotics on the chromosome, promote the efflux of the molecule and degrade 
or modify the conformation of the compounds through enzymatic actions, thus 
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favoring colonization and invasion of pathogens and, consequently, causing damage 
to the host by expressing clinical picture of infection [9, 12–14].
Li et al. in a metagenomic assay identified profiles of a wide spectrum of mul-
tiresistance genes from different environments. These profiles were correlated and 
grouped according to incidence, and the results showed a higher prevalence of 
multiresistance genes in animal feces and in residual water from farms, followed by 
sewage and human feces, STP effluents, STP ADS and STP AS & BF and, finally, in 
drinking water, rivers, soils and sediments [15].
The result by Li et al. corroborates with the identification of multiresistance 
genes in animal production environments systems from the practice of indicating 
subtherapeutic amounts of antibiotics to animals for the purpose of improving 
performance [8, 9, 15]. In addition to the zootechnical performance, the increase in 
the intensive practice of animal husbandry, with overcrowding of the sheds, absent 
or precarious hygiene and disinfection practices, increased the prophylactic use of 
antibiotics. [8]. It is estimated that 60,000 ton per year are consumed on agricul-
tural farms, and 80% of antibiotics consumed in the USA are used in livestock, with 
around 27 different antimicrobial classes being used in animals [9–11]. Antibiotics 
depending on the drug and the species treated will have an absorption or metabo-
lization range between 10–80%, with the remainder being excreted as active com-
pounds in the urine and feces to the environment. Thus, soils, water, effluents are 
contaminated and the selective pressure on the microbiota of these environments 
is selected, increasing the resistance to antibiotics [9–11]. In the holistic analysis of 
the ecosystem, each environment and living being serves as a regulator or regulated 
agent of selective pressure to multiresistance genes, serving an evolutionary cycle.
Unfortunately, global resistance to antibiotics has no tendency to decline. Data 
show that around 700,000 deaths per year worldwide are due to antimicrobial 
resistance. In Europe this number is 33,000 and the estimative of resistance to 
antibiotics represents a costs of €1.5 billion per year with healthcare expenses and 
productivity losses. In the US, the of deaths is 99,000, estimated cost with patients 
treatment is about $20 billion and the social costs reach $35 billion. In the Americas, 
about 77 million people per year fall ill after consuming contaminated food. Out 
of these, nine thousand die. In Brazil, from 2007 to 2016, 90.5% of the cases of 
foodborne diseases were caused by bacteria, mostly Salmonella spp (7.5%), followed 
by Escherichia coli (7, 2%) and Staphylococcus aureus (5.8%). Therefore, coordinated 
efforts to implement new policies to regulate the use of antibiotics, stimulate the 
research efforts and seek measures to manage the crisis are necessary to maintain 
intensive livestock productivity, animal and human health, and the ecosystem 
balance [2–4].
2.2 Animal health regulatory affairs
As an effort to reduce the antimicrobial resistance promoted by antibiotics used 
asr growth promoter, international agencies are searching to regulate a tolerance 
levels to antibiotics used for animals. The problem has been obtain similar commit-
ments by the WHO, FAO and OIE in which measures of banned or establishment 
of minimum tolerance level of the drug shall be evaluated for mitigated noise and, 
consequently, avoid opportunities to inappropriate use of antimicrobial [16].
Despite the divergences, countries have been establishing regulatory measures 
regarding the use of antibiotics as growth promoters. The Europe (EU), in 2006, 
finished the progressive elimination of antibiotics program, used as growth 
promoters, banning sodium monensin, sodium salinomycin, avilamycin and 
flavophospholipol. These final measures aim to combat the emergence of super-
bugs, due to antibiotics overexploitation or misuse [17–19]. In 2017, the European 
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Commission adopted a “EU AMR Action Plan” which the key objectives are to make 
EU an example practice region; improve the research, development and innovation; 
and, shape the global agenda. Nowadays, since the plan implementation, updates 
have been made in order to further strengthen EU’s response to AMR, such as, 
Pharmaceutical Strategy for Europe, creation of a new EU authority named Health 
Emergency Response Authority (HERA), creation of Commission Implementing 
Decision (EU) 2020/1729 for monitor and report antimicrobial resistance; adop-
tion a tool Farm to Fork Strategy for sustainable food systems, implementation of 
Regulation (EU) 2019/6 on Veterinary Medicinal Products (VMP Regulation) and 
Regulation (EU) 2019/4 on Medicated Feed (MF), an implementation of better 
animal welfare, and others [20, 21].
In United States (USA), the antibiotic reforms were difficult, marked by con-
stant clashes with the industries. Only from 2000, some formal procedures were 
started to withdrawal the antibiotics in animals for growth promoters. In 2013, 
FDA published a guidance for industry to phase out antibiotic growth promotion 
via label changes [22, 23]. In 2017, the completed implementation of guidance 
represented a changed of antimicrobial drugs used in the feed animal production. 
Of the 292 animal drug applications, 84 were banned and 208 remaining applica-
tions were converted from over the counter to prescription status or to veterinary 
feed directive status [23].
In Brazil, the Ministry of Agriculture, Livestock and Supply, through Normative 
Instruction No 45, of November 22, 2016, prohibited the import and manufacture 
of the antimicrobial substance colistin sulfate with a performance-enhancing 
zootechnical additive throughout the territory in animal feeding [24]. Ordinance 
No.195, of July 4, 2018 establishes good management practices in commercial farms, 
in order to obtain sustainable production, preserving health and well-being [25]. 
Furthermore, Ordinance No 171, of December 13, 2018, informed that the use of 
the antimicrobials tylosin, lincomycin, bacitracin and tiamulin is prohibited for the 
purpose of performance-enhancing additives in farm animals [26].
Despite the alarming situation that resistance to antimicrobials has triggered in 
public health worldwide and the repeated appeals to reduce the inclusion of antibiot-
ics in animal production by internationals agencies, many low- and middle-income 
countries do not include these recommendations in their national commitments. 
China is a country example: considered one of the largest consumers of antibiotics 
in livestock animals, elaborated a National Action Plan to Combat Antimicrobial 
Resistance from Animal Resources which regulates the withdraw all antibiotics 
used as feed additive; revised indicative use that antimicrobials are used only for 
prevention or treatment and stablished that new approvals of antimicrobials are only 
indicate for veterinary medicine [27]. South Africa, in 2018, by Africa Centers for 
Disease Control and Prevention (Africa CDC) has also developed a national frame-
work plan which aimed detect to respond the infectious diseases in country [28].
In summary, the overview commitments of the recommendations are: i) imple-
ment a global public campaign to awareness about the importance to reduce anti-
microbial used; ii) improve practical of hygiene and disinfections in daily routine 
either for human health or for animal management; iii) reduce the indiscriminate 
use of antimicrobials; iv) develop new diagnostics tools for rapid and reliable assay, 
including for accuracy monitoring antimicrobial development; v) improve manage-
ment procedures for disease prevention and control; vi) develop sustainable and 
effective substitutes for antibiotics in animal production system [29].
During recent years, efforts focused to develop and work on providing novel 
and alternative supplements for growth performance and therapeutics to prevent 
diseases and enhance animal immunity. One of the potential substitutes evaluate is 
the synbiotic additive.
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2.3 Synbiotic mode of action: an overview
The synbiotic concept is “a mixture comprising live microorganisms and 
substrate(s) selectively utilized by host microorganisms that confers a health 
benefit on the host”. The symbiotic term is a Greek word compound of prefix ‘syn’, 
meaning ‘together’ and the suffix ‘biotic’, meaning ‘pertaining to life’ [5]. The prebi-
otic and probiotic combination product might not have any co- dependent function, 
acting trough by complementary and synergistic mechanisms. Both, independently 
promote an eubiosis, a maintain physiology homeostasis, modulating the digestive 
and immune system, and others functions in the host. The synbiotic product can 
be applied to intestinal or extra-intestinal microbial ecosystems in human, animals 
and agricultural species by regulatory categories, such as, feed additive, foods, non-
foods, nutritional supplements or drugs [5].
The symbiotic formulation performs its function in a gastrointestinal tract, 
where more than 100 trillion (1014) microorganisms inhabit. The resident micro-
bial groups are affected by endogenous factors, such as, temperature, pH, oxygen 
concentration, diet, secretions, and others. Particularly, diets rich in non-digestible 
ingredient can highly modify the composition and function of gut microbiota by 
selectively influence [5, 30].
These non-digestible food ingredient as named prebiotics was described as 
“a non-digestible components of food, fiber or non-carbohydrate digestible, that 
beneficially affects the host by selectively stimulating the growth and/or activity 
of one or a limited number of bacteria in the colon, and thus improves host health” 
[5, 30–32]. The criteria for prebiotic classification are: i) resist acidic pH, digestion 
action and adsorption by their host; ii) should be metabolized or fermented by 
microorganism residing in the TGI tract; iii) should promote a microbiota selec-
tively stimulation, conferring beneficial physiological effect on the host; iv), not 
to all or poorly metabolized by pathogenic organism in gut bowel [5, 30, 31]. Most 
commonly known and characterized prebiotics include inulin, fructooligosaccha-
ride (FOS), glucooligosaccharide (GOS), mannanoligosaccharide (MOS) [5, 30–33].
Prebiotics are considered a specific fuel that indigenous probiotic bacteria can 
utilize to grow. The selective fermentation of prebiotic occurs through correla-
tion between chemical oligosaccharide structure and biochemicals metabolites of 
gut microbiota. The presence of carbon anomeric, the molecular weight and the 
number of branching present in prebiotic structure select microbiome preferences. 
For example, Bifidobacterium sp prefer to ferment low weight molecular of trisac-
charides and tetrasachhrides in a series of oligosaccharides with reduced number 
of branching [30]. Beside this, the prebiotic metabolization by gut microbiome 
are influenced by secretion of a wide range of specific enzymes such as polysac-
charidases, aminopeptidases, proteases, glycosidases, glycanases and others that 
will digest the prebiotics in a monomeric constituent. These parameters influence 
results the microbiome selective fermentation and explain the a non-digestion 
of prebiotic by host enzymes and the non-metabolization of them by pathogens 
strains, such as, Salmonella spp., E. coli, and Clostridial population [30, 32].
Furthermore, the metabolic fermentation results in a lactic acid, short-chain 
fatty acid (SCFA), or some antibacterial substances, such as bacteriocins, leading 
to a reduction of the metabolic activity of potentially harmful bacteria [30–34]. In 
general, the SCFA acts acidifying the luminal pH which suppresses the growth of 
pathogens, influence intestinal motility and acts stimulating enterocytes prolifera-
tion and mucin secretion. The rapidly absorption of SCFA by the enteric mucosa 
contributes to the quickly supply of host’s energy requirements. Furthermore, they 
can be recognized by protein coupled receptors (GPR) expressed on polymor-
phonuclear immune cells, enterocytes and enteroendocrine cells stimulating the 
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chemokine and cytokines expression, such as, pro-inflammatory IL-2 and inter-
feron (IFN)-γ and immuno-regulatory IL-10 production [30, 32, 33].
In addition, to modulating the immune system by SCFA, prebiotics can be direct 
recognized by toll-like receptors (TLRs) and NOD-like receptors (NLRs), both 
a pattern recognition receptor (PRR) present in immune membrane cells. This 
recognition will modulate the innate immune response inducing an overexpression 
of innate immune cells such as epithelial cells, macrophages, mast and dendritic 
cells. Another way of prebiotic action in immune systems is promoting the recogni-
tion of PAMPs signs by PRR, activating innate immune cells and the production of 
cytokines [30, 32, 33].
Finally, new scientific results correlate show that prebiotics also accelerate 
uptake of various micronutrients like iron, zinc, and calcium and significantly 
reduces or prevent the chances of colon-associated cancers, cholesterol, and 
elevated levels of triacylglycerols [30, 32, 33].
For establishment of health microbiota in host, probiotics play an important role 
enhancing the gut balance. Several studies revealed that supplementation of pro-
biotics has positive impacts on TGI tract development and on the immune system 
modulation, consequently, improving the feed efficiency ratio, nutrient absorption, 
growth performance and the animal productivity. Probiotics are defined as “Live 
microorganisms which when administered in adequate amounts confer a health 
benefit on the host” [35].
There are several species with probiotics abilities such as live bacteria, Bacillus 
sp., Lactobacillus sp, Bifidobacterium sp, yeast, Saccharomyces cerevisiae and 
Saccharomyces boulardii, fungi, Aspegillus, which are isolated from fermented 
products and human and animal body like as gut, breast milk, feces and other [36]. 
A good probiotic should have the following characteristics: i) the fermentation 
process should result in a minimum 1x109 CFU culture; ii) the stain should be specie 
specify with high ability to survive and multiply fast in TGI tract host; iii) should be 
stable and safe to the host, GRAS 0, resisting an acid and bile action; iv) should have 
an ability in maintaining the normal physiology of host animals by strong adhesive 
capability in TGI tract, an effective competitive exclusion to reduce pathogenic 
microorganisms, and others; v) should have a durable shelf-life of commercial 
manufacturing, processing and distribution [36, 37].
The mode of action of probiotics in animal includes: i) maintaining normal 
intestinal microflora by competitive exclusion and antagonism; ii) altering metabo-
lism by increasing digestive enzyme activity and decreasing bacterial enzyme 
activity and ammonia production; iii) improving feed intake and digestion; iv) and 
neutralizing enterotoxins and stimulating the immune system [38].
The main major mechanisms triggered by probiotics described are: i) modula-
tion of the physical–chemical environment; ii) synthesis of biologically active mole-
cules with antimicrobial properties; iii) and, modulation of the immune system.
The modulation of the physical–chemical environment of the enzymatic 
activities through the gastrointestinal tract and enzymatic activities catabolism 
stimulate the food’s energy and protein digestibility which favors, the absorp-
tion of nutrients promoting the growth of the probiotic microbiota in detriment 
of the pathogenic one by the establishment of competition between them. This 
dynamic is called competitive exclusion. Concomitant to competitive exclusion, 
probiotics are also able to decrease the gut pH, though fermentation of carbohy-
drates providing an inhospitable environment for pathogenic bacteria, which are 
more susceptible to acidic pH. This is called growth modulation by pH. Still, the 
consumption of lactic acid by lactic bacteria and yeast strains can occur, which 
will result in the buffering of the TGI tract and the production of organic acids 
and vitamins [39–41].
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Regarding the synthesis of biologically active molecules, the production of 
bacteriocins, antibiotics, free fatty acids, hydrogen peroxide is mentioned, among 
others, in particular, when there is the establishment of the probiotic microbiota 
to the gastrointestinal mucosa. These biologically active molecules control the 
proliferation and/or survival of the surrounding microorganisms. For example, 
bacteriocins are cited as peptides or proteins that kill related bacteria by permea-
bilizing their cell membranes or by interfering with the structure of their essential 
enzymes [42–44]. Another benefit comes from the increase in the concentration of 
propionate, succinate, valerate which, as precursors of gluconeogenesis, favor the 
availability of glucose to the animal, favoring the increase production, as well as its 
quality [45].
Concerning the intestinal homeostasis, there are literature describing the com-
mensal intestinal microbiota as the main modulator of host physiology. The pres-
ence of probiotics adhered to the intestinal mucosa forms the so-called intestinal 
barrier capable of reducing the installation of pathogenic microorganisms, interfer-
ing with intestinal permeability, increasing the degradation of enteric antigens, 
as well as altering their immunogenicity. The repercussion of probiotic activity in 
the intestine implies an immunological homeostasis which in adverse contexts will 
favor immunological tolerance through the development of tolerogenic dendritic 
cells, regulatory T cells, Toll-Like Receptors (TLR), production of cytokines, 
according to immunological balance patterns [46–50].
In summary, the ability of synbiotics to do a protective effect on the intestinal 
microbiota may be dependent of multiple factors regulations such as formulation 
composition, indicative use dosage, host’s genetic background, age and health 
status, hygiene and disinfections ambient conditions and treatment condition and 
duration.
2.4  From feed to health: the influence of Synbiotic commercial formulations in 
the poultry farm
In 2019, around of 100 thousand tons of poultry meat were produced in 
worldwide, being the U.S the world production leader followed by China and 
Brazil. The combined production of these countries represents half of the 
world poultry meat production [51]. In the exports, Brazil is a largest exporter 
with 4,200 ton shipped to more than 150 countries [52]. In 2020, this number 
increased on4% in production due to the national consumption increase and due 
to continuity of Chinese demand for animal protein. Also, the consumption of 
eggs increased as well [53].
This rising in the poultry production impacted in increase of 3.6% in feed 
production and, consequently, in a higher consumption of macronutrients and 
micronutrients that compose them. Around 16,494 tons of zootechnical additives 
were consumed in 2020, in which 10,144 tons were enzyme consumption, 4,947 
tons were prebiotics and probiotics and 1403 tons were performance enhancers [53].
Through a comparative analysis of this data to the same parameters rescued from 
2011, it is possible to of almost 50% in the consumption of performance enhancers 
and an increase of 1649% in the consumption of prebiotics and probiotics. In 2011, 
5,628 tons of additives were consumed in poultry production, distributed in 2,434 
tons of enzymes, 2895 tons of antibiotics growth promoter and 300 tons of prebiot-
ics and probiotics [54].
The expressive increase of prebiotics and probiotics consumption is a conse-
quence of the guidelines of the international agencies about antimicrobial resis-
tance, the prohibition of the use of certain antibiotics as a growth promoter, the 
elaboration and execution of the National Action Plan on Antimicrobial Resistance 
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in Agriculture and the adjustments in the production chain in order to comply with 
the requirements of the foreign market.
The significant changes in the growth of commercial poultry have focused on 
intestinal development from two related but different directions. The tremendous 
genetic progress for largely grown poultry at ever decreasing ages turn recognize 
the first week posthatch represent a significant period of avian development and 
have a critical influence for intestinal growth. Immediately posthatch, the small 
intestine has proportional weight as body weight and will increase around 30% at 
3 days. The contents of the residual yolk nutrients can be transferred to blood and 
intestine up 72 h, it represents a faster fed in chicks supplying their energy demand. 
At 7 days-old, the intestine will be twice as heavier weight than at day 1. Significant 
differences in villus height and crypt depth at day 3 from hatch noted, emphasizing 
the importance of intestinal development related to supporting accelerated growth 
and the importance of the intestinal given by histological measurements. A critical 
point in posthatch is the logistics of the chicks to the farm. During this period the 
birds are not feed with specific food, so they are susceptible to the environmental 
microbiota and, as a consequence, to a pathogen colonization [55, 56].
In this scenario of posthatch, in our trial research to evaluation of a commercial 
probiotic product, dispersive powder, composed by 3.5x107 CFU/g Bifidobacterium 
bifidum, 3.5x107 CFU / g Enterococcus faecium, 3, 5x107 CFU/g Lactobacillus acidophi-
lus, 4x107 CFU / g Bacillus subtilis and 4x107 CFU/g Bacillus licheniformis, indicated 
for application via spray, in the hatchery, on the chicks at a final concentration of 
1.23x107 CFU/ml, was applied in commercial layers to evaluate the microbial profile 
also too the product efficacy reduce the vulnerability that can occur by pathogen 
colonization in the gastrointestinal tract. Swabs from intestinal fragment, jejunum 
and ileum junction, were realized at times zero (D0), 7 days (D7) and 32 days (D32) 
and analyzed by next-generation sequencing technique, for evaluated the dynamic 
microbiome during the development of the gastrointestinal tract, also too, the bet-
ter eubiosis establishment when probiotic intake is provided to the hens in the first 
moment of life.
At D0, hours after supplied the hens with probiotic supplement, were identi-
fied 12 bacterial species in the samples of jejunum and ileum junction, which 3189 
reads (121 reads in treated group - SG; 3068 reads in control group - CG). The 
bacteria species identified are Aeromonas hydrophila (10 reads SG; 0 read CG), 
Bacillus foraminis (9 reads SG; 0 read CG), Bacillus persicus (5 reads SG; 0 read CG), 
Brevundimonas bullata (0 read SG; 185 reads CG), Deftia acidovorans (5 reads SG; 
0 read CG), Enterococcus faecalis (82 reads SG; 1959 reads CG), Noviherbaspirilum 
canariense (0 read SG; 137 reads CG), Ochrobactrum anthropi (5 reads SG; 0 read 
CG), Pantoea agglomerans (0 read SG; 288 reads CG), Pseusomonas koreensis (0 read 
SG; 275 reads CG), Pseudomonas putida (5 reads SG; 129 CG), Stenotrophomonas 
maltophilia (0 read SG; 95 reads CG). These microbial profiles had a statistically 
significant difference to the treatment variable (f(1) = 4.56; p-value = 0.0353), and 
to the microbial diversity variable (f(11) = 2.04; p-value = 0.0329); and statistical 
trend for the interaction between the variables treatment and microbial diversity 
(p-value = 0.0765).
In start of feed consumption, at the first day of the birds’ life (D1), hens of 
treated group were supplied with commercial product composed by 5x107 CFU/g 
Bacillus coagulans, 5x108 CFU/g Bacillus subtillis, 5x108 CFU / g Bacillus licheniformis, 
5x107 CFU/g Lactobacillus acidophilus and 2x107 CFU/g of Saccharomyces cerevisae 
and 2 g/kg Mannan oligosaccharides (MOS) was insert into the extruded feed at 
a final concentration of 2.24x105 CFU/g of feed, to continue the gastrointestinal 
and immune system modulation. The analysis of the microbiome profile, at D7, 
had have a quantification of 88989 reads (18360 reads SG; 70629 reads CG) with 
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identification of 17 bacterial strains distributed in Bacillus cereus (5 reads SG; 0 read 
CG), Butyticicoccus pullicaecorum (0 read SG; 385 reads CG); Clostridium beijerinckii 
(9 reads SG; 0 read CG), Clostridium difficile (0 read SG; 25 reads CG), Clostridium 
innocuum (0 read SG; 26 reads CG), Clostridium spiroforme (0 read SG; 243 reads 
CG), Enterococcus faecalis (0 read SG; 157 reads CG), Enterococcus gallinarum (0 
reads SG; 38 reads CG), Erysipelatoclostridium ramosum (0 reads SG; 135 reads CG), 
Kurthia gibsonii (0 reads SG; 27 reads CG), Lactobacillus gasseri (0 read SG; 7293 
reads CG), Lactobacillus helveticus (13869 reads SG; 1526 reads CG), Lactobacillus 
intestinalis (0 reads SG; 2029 reads CG), Lactobacillus johnsonii (0 read SG; 36340 
reads CG), Lactobacillus reuteri (2070 reads SG;4471 reads CG); Lactobacillus 
vaginalis (6 reads SG; 659 reads CG) and Lactobacillus oris (0 read SG; 1076 reads 
CG). These results in a statistical trend for the treatment variable (f(1) = 3.50; 
p-value = 0.0657) and a statistically significant difference for the microbial diversity 
variable (f(16) = 2.42; p-value = 0.0031), and to the interaction of these variables 
(p-value = 0.0071). In addition, at D7, greater intestinal length was observed in the 
hens of the treated group (Χ = 110.77 cm, Min = 100 cm, Max = 123 cm) compared 
to the control group (Χ = 103.5 cm, Min = 91 .5 cm, Max = 115.5 cm) resulting in a 
statistically significant difference, p-value = 0.0168.
At D32, end period of the microbial profile evaluation, there were a total quanti-
fication of 85069 reads (53042 reads SG; 32027 reads CG), with 37 bacterial strains 
identified distribute in Acinetobacter junii (0 read SG; 73 reads CG), Acinetobacter 
ursingii (0 reads SG; 106 reads CG), Brachbacterium articum (18 reads SG; 292 reads 
CG), Brachbacterium faecium (17 reads SG; 106 reads CG), Brevibacterium epider-
midis (985 SG reads; 1557 CG reads), Brevibacterium senegalense (142 SG reads; 
490 CG reads), Brevundimonas diminuta (0 SG reads; 283 CG reads), Clostridium 
ruminantium (18790 SG reads; 4844 CG reads), Comamonas kerstersii (121 SG 
reads; 0 CG reads), Corynebacterium stationis (1035 SG reads; 767 CG reads), 
Corynebacterium casei (997 SG reads; 915 CG reads), Corynebacterium nuruki (24 
SG reads; 0 CG read), Corynebacterium terpenotabidum (0 SG reads); 75 reads CG), 
Corynebacterium variabile (227 reads SG; 382 reads CG), Dietzia maris (549 reads 
SG; 0 read CG), Enterococcus cecorum (506 reads SG; 290 reads CG), Escherichia 
coli (0 read SG; 10248 reads CG), Facklamia tabacinalis (148 reads SG; 0 read CG), 
Fusobacterium mortiferum (62 reads SG; 0 reads CG), Fusobacterium necrogenes (82 
reads SG; 0 read CG), Globicatella sanguinis (35 reads SG; 0 reads CG), Lactobacillus 
agiis (0 read SG; 142 reads CG), Lactobacillus aviarius (611 reads SG; 0 read CG), 
Lactobacillus helveticus (21816 reads SG; 6348 reads CG), Lactobacillus salivaris 
(6061 reads SG; 1852 reads CG), Ochrobactrum pseudogrignonense (0 read SG; 47 
reads CG), Pantoea aeptica (0 read SG; 121 reads CG), Providencia rettgeri (95 
read SG; 0 read CG), Pseudomonas veronii (0 read SG; 41 read CG), Staphylococcus 
gallinarum (170 read SG; 178 read CG), Staphylococcus lentus (216 read SG; 0 read 
CG), Staphylococcus saprophyticus (229 read SG; 899 reads CG), Staphylococcus 
sciuri (18 reads SG; 0 read CG), Streptococcus infantarius (0 read SG; 192 reads CG), 
Streptomyces rectiviolaceus (17 reads SG; 0 reads CG), Subdoligranulum variabile (71 
reads SG; 0 reads CG) and Veillonela magna (0 read SG; 1425 reads CG). There was 
no statistical difference for the treatment variable (f(1) = 0.81; p-value = 0.3692), 
there was statistical difference for microbial diversity variable (f(36) = 2.53; 
p-value < 0.0001), and no difference statistics for the interaction between variables 
(p-value = 0.4220).
As can be seen, immediately after posthatch, colonization of the gastrointestinal 
tract of the bird begins, whose quantitative and qualitative composition presents 
distinct microbial dynamics and profiles according to the influence of the zoogenic 
conditions of the environment, the components of the diet supplied to the animal, 
the interaction of microorganisms the physiology, metabolism and immunology of 
Prebiotics and Probiotics - From Food to Health
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the host, and the dynamics of interaction between microorganisms to achieve the 
complex and dynamic establishment of the microbiota [57].
When analyzing the results of the microbial profile, at D0, the quantitative 
discrepancy of the microbial load present between the experimental groups is 
observed. Hypothetically, it is suggested that there was competitive exclusion 
between bacterial species: the environmental microbiota and the probiotic multi-
strains supplied through the commercial product. This hypothesis is based on the 
analysis of the microbial distribution profile in the intestinal fragment in which 
an approximate percentage of pathogenic bacteria colonizing both experimental 
groups is observed, but with a lower microbial load in the treated group. As an 
example, there was a prevalence of colonization of Enterococcus faecalis strains (82 
reads SG, 68%; 1959 reads CG, 61%; FC = 23.89) followed by Pseudomonas putida  
(5 reads SG, 4%; 129 reads CG, 4%; FC = 25.8) in both groups, however, in the 
control group the presence of 23.89 more Enterococcus faecalis and 25.8 more 
Pseudomonas putida is observed in relation to the treated group.
These same pathogenic strains prevalent at D0 are suppressed from the micro-
bial profile at D7, at distribution of Enterococcus spp being 0.27% in the control 
group and 0% in the treated group. The genus Pseudomonas spp is absent in both 
experimental groups, which shows the occurrence of competitive exclusion in the 
colonization of the intestinal fragment. Still, at D7, when analyzing the microbial 
profile of the experimental groups, the control group showed the greatest diversity 
and quantity of bacterial strains colonizing the intestinal fragment, with a preva-
lence of 98.53% of lactic strains and the presence of pathogenic strains with 0.41% 
Clostridium spp and 0.27% Enterococcus spp. Meanwhile, the treated group had 
lower microbial diversity, but higher prevalence of lactic strains (99.92%).
This dynamic microbiota in the first life stage of chicken was also reported 
by Śliżewska et al. [58] since the posthatch, in which they observe a prevalence 
of coli, enterococcus and lactic bacteria genera present in the crop, duodenum 
and jejunum. In the first and second weeks of life, they described the prevalence 
of the Lactobacillus spp. genera in the composition of the gastrointestinal tract 
and, in the third week, the microbial constitution was distributed in Lactobacillus 
spp. (70%), Clostridium spp. (11%), Streptococcus spp. (6.5%), Enterobacteriaceae 
family bacteria (6.5%), Enterococcus spp. (6%), corroborating a distribution of 
a microbial profile close to that identified in our results. Another common cor-
relation identified was the significant reduction of potential pathogenic bacteria 
such as Escherichia coli and Clostridium spp when adding the symbiotic in the feed. 
In summary, both results show the beneficial effects of the consumption of the 
synbiotic in favoring sanitary control by establishing the balance of the intestinal 
microbiota.
At D32, the period reported in the literature for the establishment of eubiosis, 
effective bacterial diversity is observed in both experimental groups, and in eubio-
sis the group treated with commercial synbiotic product had a higher and better 
microbial profile. It should be noted that the prevalence of probiotic strains in the 
treated group throughout the experiment, even with a smaller amount of reads 
identified at D0 and D7, favored the establishment of eubiosis with the proliferation 
of other lactic strains that benefited the development and maturation of the treat-
ment. Gastrointestinal tract of birds. While the control group had 26% probiotic 
strains (Lactobacillus agiis, Lactobacillus helveticus and Lactobacillus salivaris), 32% 
Escherichia coli, 4% Staphylococcus spp and other environmental strains, the treated 
group had 54% probiotic strains (Lactobacillus aviarius, Lactobacillus helveticus and 
Lactobacillus salivaris), absence of Escherichia coli, 1% Staphylococcus ssp and other 
environmental strains, showing the impact of consumption of the synbiotic for the 
establishment of eubiosis with a better microbial profile in hens.
11
The Domino Effects of Synbiotic: From Feed to Health
DOI: http://dx.doi.org/10.5772/intechopen.99733
Adhikari [59] described the distribution of lactic strains along the gastrointes-
tinal tract of birds correlated with what was identified in our results. This reports 
the identification of greater abundance of Lactobacillus salivarius and Lactobacillus 
johnsonii in all intestinal fragments analyzed: cecal lumen, cecal mucosa and ileum 
mucosa, with the highest concentration of lactic strains identified in the ileum 
mucosa and cecal lumen followed by the cecal mucosa. Similar colonization profiles 
of lactic strains were described by Ranjitkar et al. [60] and Wang et al. [61].
Dunislawska et al. [62] corroborate the benefits of consumption of synbiotics by 
describing effects of consumption of microflora-promoting bioactive compounds, 
even in a single dose of prebiotic or synbiotic in ovo and immediately posthatch, in 
interfering with the dynamics of microbiota colonization as well as across the entire 
spectrum of phenotypic characteristics in the broiler development stages, including 
zootechnical performance, development and modulation of the immune system, 
development and histological composition of the gastrointestinal tract, change in 
molecular expression in cecal tonsils, spleen and liver, change in the composition of 
meat quality.
The reflection of this dynamics of colonization of the gastrointestinal tract 
of birds has repercussions in various field scenarios in the results of zootechni-
cal performance, in sanitary control and in the reduction of antimicrobial pulses 
administered to the birds. To report this scenario of the reality of the field, whose 
management variables are diverse and often distinct from each other, one of our 
field trials is presented. This assay was carried out on a commercial poultry farm 
producing broilers, which houses about 7,000,000 birds per month. Two farms, 
Farm 1 and Farm 2, composed of 15 and 16 sheds respectively, housed Ross lineage 
birds. Farm 1 had in its ambience a cepillo’s bed, dating back to 1st and 2nd, con-
ventional lighting, side plates and an oven per aviary. Farm 2 had a cepillo’s bed, 
dating back to no. 2, dark lighting, side and front plates and two ovens per aviary. As 
for the treatment, the commercial synbiotic product was composed of 5x107 CFU/g 
Bacillus coagulans, 5x108 CFU/g Bacillus subtillis, 5x108 CFU/g Bacillus licheniformis, 
5x107 CFU/g Lactobacillus acidophilus and 2x107 CFU/g of Saccharomyces cerevisae 
and 2 g/kg Mananooligosaccharide was administered on extruded feed mixture at 
a final concentration of 1.02x105 CFU/g feed at farm 1, while poultries from farm 2 
received the probiotic product consisting of 1x108 CFU CFU/g Bifidobacterium ani-
malis, 6x108 CFU CFU/g Enterococcus faecium, 2,5x107 CFU/g Lactobacillus reuteri, 
2,5x107 CFU/g Lactobacillus salivarius, 2,5x108 CFU/g CFU/g Pediococcus acidilactici 
added to the extruded feed with final concentration of 1.00x105 UFC/g of feed. 
Farm 1 will be named as the treated group and farm 2 as the control group.
In terms of zootechnical performance, there were no statistical differences 
between both treatments, at the seventh day (D7), regarding weight gain, 
p-value = 0.966 (control group X = 183.2 g, Min = 159 g, Max = 203 g; treated 
group X = 185.4 g, Min = 167 g, Max = 228 g) and as for intestinal length, 
p-value = 0.977 (control group X = 106.2 cm, Min = 90 cm, Max = 122 cm; 
treated group X = 107.2 cm, Min = 94 cm, Max = 124 cm); at D14, as for weight 
gain, p-value = 0.6111 (control group X = 510.3 g, Min = 400 g, Max = 572 g; 
treated group X = 510.2 g, Min = 473 g, Max =542 g) and as for intestinal length, 
p-value = 0.114 (control group X = 137.9 cm, Min = 115 cm, Max = 166 cm; 
treated group X = 144.1 cm, Min = 125 cm, Max = 174 cm); at D21, as for weight 
gain, p-value = 0.368 (control group X = 1014 g, Min = 969 g, Max = 1118 g; 
treated group X = 1019 g, Min = 878 g, Max = 1145 g) and as for intestinal length, 
p-value = 0.160 (control group X = 164.2 cm, Min = 148 cm, Max = 178 cm; treated 
group X = 169.8 cm, Min = 153 cm, Max = 198 cm); at D28, as for weight gain, 
p-value = 0.989 (control group X = 1596 g, Min = 1435 g, Max = 1702 g; treated 
group X = 1600 g, Min = 1441 g, Max = 1763 g) and as for intestinal length, 
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p-value = 0.808 (control group X = 187.6 cm, Min = 160 cm, Max = 220 cm; treated 
group X = 185.7 cm, Min = 166 cm, Max = 207 cm).
Despite the absence of significant statistics in the above results, at the end of 
the management, the treated group showed better performance in relation to the 
zootechnical results, as they had greater daily weight gain (control group = 68.82 g; 
treated group = 71.34 g), greater corrected slaughter weight (control group = 2573 g; 
treated group = 2853 g), better feed conversion (control group = 1.593; treated 
group = 1.571), consequently, better productivity factor (control group = 413.19; 
treated group = 430. 89). The only zootechnical results of the treated group with 
lower performance than the control group were the mortality parameter (control 
group = 4.27%; treated group = 5.17%) whose established hypothesis refers to the 
ambience, the presence of a single oven in the aviary, and the thermal challenges, 
variations from 8–25°C throughout the day, that the birds in the treated group went 
through in the first week of bird life.
As for sanitary control, it is routine in the management of farms to carry out at 
D21 the evaluation of the identification of the presence/absence of salmonella in 
the sheds using a drag swab, performing both polymerase chain reaction (PCR) 
methodology and the conventional method of microbial cultivation. The results 
for the PCR assay showed 4 positive samples for the control group and 2 positive 
samples for the treated group, while, for the conventional method of microbial 
cultivation, the control group showed 2 positive samples while the treated group 
did not show characteristic culture growth. These results show the best sanitary 
control of the synbiotic product to the sanitary control for salmonella. It is note-
worthy that this drag swab is carried out in the bed of the sheds and does not 
necessarily reflect the presence of salmonella in the cecal content of the poultries. 
Further tests carried out in other poultry farms whose house received the treat-
ment of the synbiotic product, despite showing identification of salmonella in 
the house and outside areas, did not show identification of salmonella in the cecal 
content of poultries.
As for the consumption of antibiotics, there was a significant reduction in the 
consumption of antibiotics in the treated group compared to the control group 
(FC = 0.37). The treated group consumed throughout the management three 
types of antibiotics which total of 33 administration pulses, while the control 
group consumed four types of antibiotics, totaling 89 administration pulses. 
The description of antibiotic consumption in the control group was, at D1, four 
aviaries received pulses of the antibiotic Cipronil for five days; at D7, seven farms 
received Trimoxil pulses for three days; at D9, 1 aviary also received Trimoxil 
for three days; at D13, 3 farms received Farmaxilin pulses for three days; at D20, 
three farms received Cipronil pulses for five days, two farms received Farmaxilin 
pulses for three days; and, at D28, one house received Farmaxilin pulses for three 
days and four houses received Amprol Base pulses for two days. While the birds 
in the treated group, distributed in 15 aviaries, at D7, three aviaries received 
Farmaxilin pulses for three days; at D18, two farms received three Farmaxilin 
pulses; at D26, two aviaries received three pulses of Amprol Base; at D29, one 
aviary received three pulses of Cipronil and three aviaries received three pulses of 
also Amprol Base.
There is an adversity in comparing the results of zootechnical performance 
obtained on the commercial farm with results published in the literature, as the 
indications for use of synbiotic products and the experimental environment 
variables are distinct and extrapolate the behavior of commercial products in the 
development of the gastrointestinal tract of birds. In short, when evaluating the 
results described by Syed et al. [63] whose treatment 4 (T4) used the same com-
mercial synbiotic product present in the control group, but with an indication 
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for use 5.00x105 CFU/g of feed, if the control group had a lower performance in 
body weight gain than reported by the authors, but with a performance similar 
to that observed by the treated group whose inclusion of synbiotic product was 
five times more lower (BWG = 2573 g CG, BWG = 2983.9 g T4 and BWG = 2853 g 
SG). The feed conversion rate also differs in the experimental and field settings, 
in this variable, the corrected feed conversion rate was better in the treated group, 
followed by the control group and treatment 4 (FCR = 1.57 SG, FCR = 1.59 CG 
and FCR = 1.87 T4). Finally, mortality, whose treatment 4 showed better results 
compared to the control group and the treated group (Mortality (%) = 1.11 T4, 
Mortality (%) = 4.27 CG and Mortality (%) = 5.17 SG). In conclusion, the treated 
group prevailed with better results in 2 of the 3 variables compared in zootechnical 
performance. The zootechnical results obtained in both experiments are a reflec-
tion of several variables such as management and ambience protocols, nutritional 
quality of the feed as well as the composition and indication of use of zootechnical 
additives, environment and sanitary challenges. And, these results are reproduced 
and can also be compared to the results described by Śliżewska et al. [58], Abdel-
Wareth et al. [64] and others.
Synbiotic products in sanitary control promote resistance to infections by 
favoring morphological changes to the intestinal mucosa, developing longer villus, 
smaller crypts and better villus/crypt ratios, also by reducing the gastrointestinal 
pH due to higher lactic acids and by mitigating frequency and histopathological 
lesions [64]. Results described by Mora et al. [65] report the sanitary control of 
Salmonella Typhimurium and Clostridium Perfringens when birds are supplemented 
with symbiotics. Shanmugasundaram et al. [66], Markazi et al. [67], Luoma et al. 
[68], Asahara et al. [69], also report a reduction in salmonella proliferation in the 
cecum of birds.
It was not possible to carry out a comparative evaluation of the reduction in the 
consumption of antibiotics in therapeutic dosages, as a result of the use of synbiot-
ics in the animals’ diet and also of different compositions of synbiotics. The results 
presented are unprecedented and effectively report the benefits that the consump-
tion of certain synbiotics influences on the modulation of animal health and reflects 
on the residual reduction of these antimicrobial agents in meat and the environ-
ment, as well as on the operational result of the creation.
It is in this dual scenario between science and the reality of the field that it is 
important to highlight the equalization between basic science and the application 
of development and innovation carried out in research centers, because although 
experimental tests are essential for the development and proof of new products, the 
reality of management on commercial farms presents adverse variables and chal-
lenges, often even unpredictable, that will compromise the zootechnical perfor-
mance of the birds, the final quality of this food and, consequently, the operating 
result of the farm, on the health of the final consumer that consumes the food and 
in the environment that receives the residues from the handling operation.
The complexity of correlating the mode of action of synbiotic effects in poultry 
production demonstrates the wide spectrum of opportunities that science has to 
develop to understand all pathways influenced by prebiotics and probiotics in the 
TGI tract. Scientific results showed a specific interaction with the environment, the 
host and the synbiotic formulation. In addition, it demonstrated that the synbiotic 
participates in metabolic pathways little described in the scientific literature.
In summary, the results of scientific and field tests have shown a beneficial 
effect of all elaborated synbiotics on the balance of the intestinal microbiota, its 
metabolism and the performance of broiler chickens. Supports the ability of com-
mercial synbiotic products to replace the use of antibiotics as a growth performance 
in order to mitigate rising antimicrobial resistance.
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3. Conclusion
Synbiotic formulations are a potential choice to withdraw antibiotic as growth 
promoter. The complementary or synergic action of synbiotic improve the poultry 
production and control infections disease. Further studies should be developed to 
identify target microorganism’s species according to farm management conditions. 
The hope is that, going forward, the prebiotic, probiotic or synbiotic will have 
greater representativeness among feed additive, reducing the use of antibiotics 
and the selective pressure of microorganism. Advances in symbiotic research will 
promote better understanding of interested parties, enabling better communication 
with consumers.
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